- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02527278
Retrospective Claims Analysis of Hysterectomy After Sterilization
March 20, 2017 updated by: Bayer
A Retrospective Claims Analysis to Calculate the Proportion of Women Undergoing Hysterectomy, Salpingectomy, Salpingostomy, Hysteroscopy or Who Had a Diagnosis of Pelvic Pain After Hysteroscopic Sterilization or Laparoscopic Tubal Ligation
The research questions are:
- What is the proportion of women undergoing hysterectomy after hysteroscopic sterilization or laparoscopic tubal ligation?
- What is the proportion of women undergoing salpingectomy, salpingostomy, or hysteroscopy after hysteroscopic sterilization or laparoscopic tubal ligation?
- What is the proportion of women who have a diagnosis of pelvic pain after hysteroscopic sterilization or laparoscopic tubal ligation?
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
19317
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Whippany, New Jersey, United States
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 49 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women aged 18 - 49 at the time of the sterilization procedure from an administrative claims database
Description
Inclusion Criteria:
- Women aged 18 through 49 years at the index date
- at least one claim of the hysteroscopic sterilization procedure or interval laparoscopic tubal ligation at any time during January 1, 2010 -December 31, 2012
- Had 6 months of continuous medical and pharmacy benefits pre-index date which is considered the baseline period to capture all patient characteristics prior to the procedure
- Had 12 months of continuous medical and pharmacy benefits post-index date (i.e., follow-up period)
Exclusion Criteria:
- Women who underwent a postpartum tubal ligation procedure during the entire study period
- Women who had claims of a sterilization procedure during the baseline period
- Women who had a claim for pregnancy or delivery within 6 weeks prior to the index date
- Women who had more than one type of sterilization procedure (i.e., combination of hysteroscopic sterilization, laparoscopic tubal ligation or mini-laparotomy) on the same index date
- Women who had concurrent procedures on the same day as the index sterilization procedure that were performed for reasons beyond the purpose of sterilization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Laparoscopic tubal ligation (no pain)
Women who have laparoscopic tubal ligation, with no previous diagnosis of pain at baseline
|
Female permanent birth control method performed via a surgical procedure
|
|
Laparoscopic tubal ligation (pain)
Women who have laparoscopic tubal ligation, with a previous diagnosis of pain at baseline
|
Female permanent birth control method performed via a surgical procedure
|
|
Hysteroscopic sterilization (no pain)
Women who have hysteroscopic sterilization, with no previous diagnosis of pain at baseline
|
Female permanent birth control method performed via placement of a device
|
|
Hysteroscopic sterilization (pain)
Women who have hysteroscopic sterilization, with a previous diagnosis of pain at baseline
|
Female permanent birth control method performed via placement of a device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of women undergoing hysterectomy after hysteroscopic sterilization or laparoscopic tubal ligation
Time Frame: Within 12 months after the procedure
|
Within 12 months after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of women undergoing salpingectomy after hysteroscopic sterilization or laparoscopic tubal ligation
Time Frame: Within 12 months after the procedure
|
Within 12 months after the procedure
|
|
Proportion of women undergoing salpingostomy after hysteroscopic sterilization or laparoscopic tubal ligation
Time Frame: Within 12 months after the procedure
|
Within 12 months after the procedure
|
|
Proportion of women undergoing hysteroscopy after hysteroscopic sterilization or laparoscopic tubal ligation
Time Frame: Within 12 months after the procedure
|
Within 12 months after the procedure
|
|
Proportion of women who have a diagnosis of pelvic pain after hysteroscopic sterilization or laparoscopic tubal ligation
Time Frame: Within 12 months after the procedure
|
Within 12 months after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 30, 2015
Primary Completion (Actual)
February 9, 2016
Study Completion (Actual)
February 9, 2016
Study Registration Dates
First Submitted
August 17, 2015
First Submitted That Met QC Criteria
August 17, 2015
First Posted (Estimate)
August 18, 2015
Study Record Updates
Last Update Posted (Actual)
March 21, 2017
Last Update Submitted That Met QC Criteria
March 20, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 18477
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Montefiore Medical CenterSociety of Family PlanningCompletedContraception | Breastfeeding | Postpartum ContraceptionUnited States
Clinical Trials on Laparoscopic tubal ligation
-
Göteborg UniversityUmeå UniversityActive, not recruitingLaparoscopy | Ovarian Reserve | Salpingectomy | Sterilization TubalSweden
-
University of VirginiaCompletedMethod of Tubal Ligation at the Time of Cesarean SectionUnited States
-
Wolfson Medical CenterUnknown
-
Mayo ClinicCompletedContraceptionUnited States
-
University of Alabama at BirminghamCompletedOvarian CancerUnited States
-
EngenderHealthUnited States Agency for International Development (USAID); Tanzania Ministry... and other collaboratorsCompletedSterilization, TubalTanzania
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, FranceRecruiting
-
Femasys Inc.Completed